iShares Healthcare Innovation UCITS ETF

The iShares Healthcare Innovation UCITS ETF most frequently appears alongside broad global equity trackers like VWCE and IWDA, which often form the core of these portfolios at 60 percent or higher. Other common companions include thematic tech ETFs such as VVSM and various semiconductor holdings, alongside alternative assets like crypto and real estate. These assets serve to balance the specific volatility of the healthcare innovation sector with broader market exposure, allowing investors to capture high-growth thematic trends while maintaining a foundation of diversified global stocks and defensive bond or money market instruments.

EuroFolio members consistently utilize HEAL as a satellite holding, typically allocating between 2 and 5 percent of their total portfolio value. This suggests that investors view the asset as a tactical growth play rather than a core position, using it to gain exposure to medical advancements within more aggressive, tech-heavy strategies like V1 lightspeed or as a minor thematic tilt within balanced, multi-asset portfolios. The low allocation percentage across all top-rated portfolios indicates a disciplined approach to risk management, ensuring that the inherent volatility of the healthcare innovation sector does not disproportionately impact the overall portfolio Sharpe ratio.